BOTHELL, Wash.--(BUSINESS WIRE)--Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer, is scheduled to present at the 2009 Boston Biotech R&D Conference at 11:40 a.m. EDT on October 27, 2009 at Harvard Medical School in Cambridge, Massachusetts. The conference will bring together scientific leaders from top academic institutions that have been instrumental in establishing the strong Boston research community, executives from several of the area’s most promising and innovative biopharmaceutical companies, and principals from the venture capital community and equity markets.
